SLB Wins Oman Contract, Positive But Not Thesis-Changing

What happened

SLB has been awarded a contract by OQEP to design, build, and operate the Bisat-B Expansion Production Facility in Oman, increasing its gross fluids handling capacity to 548,000 barrels per day. The award includes engineering, procurement, construction, commissioning, and four years of operations and maintenance support, reinforcing SLB's integrated project capabilities. This win signals continued customer spending in the Middle East, albeit in Oman rather than more disrupted areas, which supports SLB's international revenue recovery narrative. However, the contract value and timeline are undisclosed, and revenue recognition will likely be spread over several years, limiting near-term earnings impact. Given the master report's WAIT rating based on margin recovery and free cash flow concerns, this award is a positive data point but insufficient to upgrade the thesis.

Implication

The award reinforces SLB's ability to win integrated EPC projects internationally and adds to backlog, but it does not change the core investment thesis. The project will contribute to future revenue and production systems mix, yet typical oilfield project timelines mean the impact on near-term earnings is limited. The master report's concerns about Well Construction pricing pressure, Digital mix, and weak free cash flow remain unresolved. We await Q2 and Q3 results to confirm whether Middle East revenue stabilizes sequentially and adjusted EBITDA margins recover above 21.5%. Until then, the stock appears fairly valued at current levels, with better risk-reward if it pulls back to the attractive entry zone.

Thesis delta

The new contract provides modest support for SLB's international and production systems narrative, indicating that customers in less disrupted Middle East countries are still spending. However, it is insufficient to change the WAIT rating, as the key catalysts—margin recovery, Digital ARR growth, and free cash flow normalization—are still pending. The stock remains range-bound, and we maintain our price targets.